ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1645–1656 of 2020 project topics
Pantothenate Kinase PANK2 Mutation Detection SaaS
A cloud-based diagnostic platform that sequences and analyzes PANK2 gene variants in PKAN patients with automated interpretation algorithms. This enables rapid clinical diagnosis and supports pharma companies running clinical trials for PKAN therapeutics, generating recurring subscription revenue from hospitals and genetic testing labs.
Genetic Basis of Basal Ganglia Disorders Click to view more details →
Mitochondrial Membrane Protein MPV17 Screening Tool Suite
An integrated bioinformatics tool that identifies pathogenic MPV17 mutations associated with mitochondrial neurogastrointestinal encephalopathy in basal ganglia tissues. This proprietary software accelerates patient stratification for gene therapy development, creating licensing opportunities with biotech companies developing MPV17-targeted treatments.
Genetic Basis of Basal Ganglia Disorders Click to view more details →
Aceruloplasminemia CP Gene Carrier Risk Assessment Platform
A predictive analytics platform that quantifies disease penetrance and progression risk for CP gene variants in aceruloplasminemia patients using machine learning models. This service enables precision medicine workflows in neurology clinics and supports insurance companies with risk stratification, creating B2B SaaS revenue streams.
Genetic Basis of Basal Ganglia Disorders Click to view more details →
Spinocerebellar Ataxia Type 17 TATA-Binding Protein Analysis
A specialized genetic testing service that quantifies CAG repeat expansions in the TBP gene with high-resolution capillary electrophoresis and digital analysis workflows. This commercial service provides critical diagnostics for SCA17 patients while generating revenue through test fees and CRO partnerships with pharmaceutical companies.
Genetic Basis of Basal Ganglia Disorders Click to view more details →
Juvenile Huntington Disease HTT CAG Repeat Expansion Prediction
An AI-powered predictive platform that forecasts juvenile-onset Huntington''s disease severity and age-of-onset based on HTT gene CAG repeat length and genetic modifiers. This tool captures value through licensing agreements with clinical trial networks and neurodegenerative disease research organizations seeking precise phenotype prediction.
Genetic Basis of Basal Ganglia Disorders Click to view more details →
Fragile X Associated Tremor Ataxia FMR1 Premutation Portal
A digital health portal that tracks FMR1 CGG repeat expansion progression and symptom correlations in FXTAS patients with longitudinal data analytics. This connected platform generates recurring revenue through patient subscriptions, provider licensing, and real-world evidence sales to pharmaceutical companies developing neuroprotective therapies.
Genetic Basis of Basal Ganglia Disorders Click to view more details →
HLA Screening for Serious Adverse Drug Reactions
Developing and implementing HLA pre-prescription testing programs for drugs including abacavir, carbamazepine, and allopurinol to prevent severe hypersensitivity.
Genetic Pharmacovigilance Programs Click to view more details →
Pharmacogenomics Surveillance Database Development
Building population-level databases linking pharmacogenomics data with adverse drug reactions for identifying novel genetic risk factors.
Genetic Pharmacovigilance Programs Click to view more details →
Automated Pharmacogenomics Alert System
Implementing EHR-integrated automated alert systems that flag pharmacogenomics test results at drug prescribing to prevent predictable adverse reactions.
Genetic Pharmacovigilance Programs Click to view more details →
Real-World Evidence for Pharmacogenomics Benefits
Generating real-world evidence for pharmacogenomics-guided prescribing by analyzing health outcomes in large EHR-linked genomic databases.
Genetic Pharmacovigilance Programs Click to view more details →
Genetic Biomarker Integration Platform for Multi-Drug Safety
A SaaS platform that integrates genetic biomarker data with electronic health records to identify patient populations at risk from polypharmacy adverse events. This delivers recurring subscription revenue while reducing client liability through proactive risk stratification and regulatory compliance documentation.
Genetic Pharmacovigilance Programs Click to view more details →
Predictive Pharmacogenomic Risk Scoring Engine for Payers
A commercial software tool that scores medication-genetics risk profiles for insurance companies and pharmacy benefit managers to optimize formulary decisions and prior authorization workflows. This generates licensing fees and cost-savings rebates by preventing expensive adverse events and reducing hospitalization rates.
Genetic Pharmacovigilance Programs Click to view more details →